Atlas Trials

Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia

Clinical trial NCT03651102 · COMPLETED

Trial details

NCT number
NCT03651102
Sponsor
Blood Diseases Clinic
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Thalassemia
Start date
2018-01-01
Primary completion
2021-11-30
Enrollment
654

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.